Targeting Prostaglandin E EP Receptors to Inhibit Metastasis
Open Access
- 15 October 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (20), 9794-9797
- https://doi.org/10.1158/0008-5472.can-06-2067
Abstract
It is well established that high cyclooxygenase-2 (COX-2) expression contributes to the aggressive behavior of breast and other malignancies. Due to concerns regarding the safety of long-term use of COX-2 inhibitors as well as a desire to seek more effective alternatives to prevent and treat metastatic disease, we tested the hypothesis that inhibition of downstream signaling by the COX-2 product prostaglandin E2 (PGE2) would be as effective as inhibiting global prostaglandin synthesis. PGE2 acts through four G-protein–coupled receptors designated EP1-4. Here, we summarize data from many laboratories regarding the role of individual E-series of prostaglandin (EP) receptors on cancer behavior and we discuss our own recent findings that antagonists of the PGE receptor subtype 4, EP4, inhibit experimental metastasis in a murine model of hormone-resistant, metastatic breast cancer. These initial results indicate that selective targeting of individual EP receptors should be investigated as an approach to exploit the high COX-2 activity in many epithelial malignancies. (Cancer Res 2006; 66(20): 9794-7)Keywords
This publication has 29 references indexed in Scilit:
- Prostaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer MetastasisCancer Research, 2006
- Increased EP4 Receptor Expression in Colorectal Cancer Progression Promotes Cell Growth and Anchorage IndependenceCancer Research, 2006
- Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor DevelopmentCancer Research, 2005
- The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary HyperplasiaCancer Research, 2005
- Cardiovascular hazard and non-steroidal anti-inflammatory drugsCurrent Opinion in Pharmacology, 2005
- EXPRESSION OF CYCLOOXYGENASE-2 AND EP4 RECEPTOR IN TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACTJournal of Urology, 2005
- Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 2003
- Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?Trends in Pharmacological Sciences, 2003
- Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor GrowthThe Journal of Experimental Medicine, 2003
- Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasisCellular Immunology, 1986